What is the official website of Eurofins Danmark - Laboratorium ?

The official website of Eurofins Danmark - Laboratorium is http://www.eurofins.dk.

What is Eurofins Danmark - Laboratorium's cybersecurity risk score?

Eurofins Danmark - Laboratorium has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eurofins Danmark - Laboratorium experienced?

According to Rankiteo, Eurofins Danmark - Laboratorium currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eurofins Danmark - Laboratorium been affected by any supply chain cyber incidents ?

According to Rankiteo, Eurofins Danmark - Laboratorium has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eurofins Danmark - Laboratorium have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins Danmark - Laboratorium is not certified under SOC 2 Type 1.

Does Eurofins Danmark - Laboratorium have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins Danmark - Laboratorium does not hold a SOC 2 Type 2 certification.

Does Eurofins Danmark - Laboratorium comply with GDPR ?

According to Rankiteo, Eurofins Danmark - Laboratorium is not listed as GDPR compliant.

Does Eurofins Danmark - Laboratorium have PCI DSS certification ?

According to Rankiteo, Eurofins Danmark - Laboratorium does not currently maintain PCI DSS compliance.

Does Eurofins Danmark - Laboratorium comply with HIPAA ?

According to Rankiteo, Eurofins Danmark - Laboratorium is not compliant with HIPAA regulations.

Does Eurofins Danmark - Laboratorium have ISO 27001 certification ?

According to Rankiteo,Eurofins Danmark - Laboratorium is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eurofins Danmark - Laboratorium operate in ?

Eurofins Danmark - Laboratorium operates primarily in the Biotechnology Research industry.

How many employees does Eurofins Danmark - Laboratorium have ?

Eurofins Danmark - Laboratorium employs approximately 0 people worldwide.

Does Eurofins Danmark - Laboratorium own any subsidiaries ?

Eurofins Danmark - Laboratorium presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eurofins Danmark - Laboratorium have ?

Eurofins Danmark - Laboratorium's official LinkedIn profile has approximately 8,098 followers.

Does Eurofins Danmark - Laboratorium have a Crunchbase profile ?

No, Eurofins Danmark - Laboratorium does not have a profile on Crunchbase.

Does Eurofins Danmark - Laboratorium have a LinkedIn profile ?

Yes, Eurofins Danmark - Laboratorium maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/eurofins-danmark.

How many cybersecurity incidents has Eurofins Danmark - Laboratorium experienced ?

As of June 16, 2026, Rankiteo reports that Eurofins Danmark - Laboratorium has not experienced any cybersecurity incidents.

How many peer or competitor companies does Eurofins Danmark - Laboratorium have ?

Eurofins Danmark - Laboratorium has an estimated 4,704 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

EDL

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Eurofins Danmark - Laboratorium Vendor Cyber Rating & Cyber Score

eurofins.dk

Add Your Compliance Badge

Vil du være med til at teste alt fra jord til bord? Så er Eurofins stedet for dig. Eurofins er nemlig førende inden for Testing For Life - hvilket betyder, at vi laver næsten alle former for analyser og ydelser til områderne miljø, DNA-analyser, fødevarer, foder, materialer og produkter samt pharma. Vores laboratorier i Danmark er beliggende i Vejen, Glostrup, Ishøj, Aabybro, Aarhus og Galten. I Danmark er vi mere end 1.100 kollegaer, og vi er altid på udkig efter talentfulde og højt motiverede medarbejdere. På denne side kan du blive klogere på. hvordan Eurofins er som arbejdsplads.

EDL A.I CyberSecurity Scoring

Scoring History

EDL

Eurofins Danmark - Laboratorium CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

EDL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for EDL

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Eurofins Danmark - Laboratorium in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins Danmark - Laboratorium in 2026.

Incident Types EDL vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Eurofins Danmark - Laboratorium in 2026.

Incident History - EDL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eurofins Danmark - Laboratorium Subsidiaries

EDL

Biotechnology Research

Website: http://www.eurofins.dk

Company Size: 0

EurofinsBiotechnology Research

Eurofins Clinical Trial SolutionsBiotechnology Research

Eurofins Lancaster LaboratoriesBiotechnology Research

Eurofins PSS Insourcing SolutionsBiotechnology Research

Eurofins BioPharma Product Testing ItalyPharmaceutical Manufacturing

Eurofins AdvinusResearch Services

Eurofins Advinus Agrosciences IndiaResearch Services

Eurofins Discovery Services IndiaResearch

Eurofins BioPharma Product Testing India Pharmaceutical Manufacturing

Eurofins IT Delivery CenterIT Services and IT Consulting

Eurofins Agroscience ServicesResearch

Eurofins Agroscience Biological SolutionsResearch

Eurofins Agroscience Seed ServicesResearch Services

Eurofins Agroscience Regulatory ConsultancyResearch Services

Eurofins Agroscience Biological AssessmentResearch Services

Eurofins Agroscience Environmental SafetyResearch

Eurofins Agroscience Consumer/Human SafetyResearch Services

Eurofins Agroscience Product ChemistryResearch Services

Eurofins do Brasil Análises de Alimentos e AmbientaisResearch Services

Eurofins GenomicsBiotechnology Research

Eurofins Environment Testing (USA)Environmental Services

Eurofins Food AssuranceProfessional Services

Eurofins Food, Feed & Water BeneluxBiotechnology Research

Eurofins DiscoverXBiotechnology Research

Eurofins Agro & HortiResearch Services

Eurofins Genomics AmericasBiotechnology

Eurofins CanadaBiotechnology Research

Eurofins Environment BeneluxEnvironmental Services

DiatherixBiotechnology Research

Eurofins ViracorMedical and Diagnostic Laboratories

ExPeCT™ anti-CD19 (FMC63) CAR TMedical and Diagnostic Laboratories

Eurofins Viracor CMV TestingBiotechnology Research

TTViWATCH™ - Torque Teno Virus qPCRMedical and Diagnostic Laboratories

Eurofins ChileFood and Beverage Services

Eurofins Biopharma Product Testing (France)Pharmaceutical Manufacturing

Eurofins Analyses Alimentaires FranceBiotechnology Research

Eurofins DiscoveryBiotechnology

Eurofins Central LaboratoryBiotechnology Research

Eurofins US Food, Feed, & Supplement TestingBiotechnology Research

Eurofins Clinical DiagnosticsBiotechnology

Eurofins CDMOPharmaceutical Manufacturing

Eurofins CDMO AlphoraPharmaceutical Manufacturing

Eurofins Environment Testing FranceBiotechnology

Eurofins | Solutions DurablesServices de conseil en environnement

Eurofins Hygiène HospitalièreBiotechnology Research

Eurofins BiomnisMedical and Diagnostic Laboratories

Eurofins Steins LaboratoriumBiotechnology Research

Eurofins Product Testing Denmark A/SSecurity and Investigations

Loading…

Eurofins Danmark - Laboratorium Similar Companies

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Loading…

NEWS

Eurofins Danmark - Laboratorium CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53430

SUMMARY

Improper Handling of Highly Compressed Data (Data Amplification) vulnerability in elixir-grpc grpc (GRPC.Compressor.Gzip, GRPC.Message modules) allows a denial of service via a gzip decompression bomb. This vulnerability is associated with program files lib/grpc/compressor/gzip.ex, lib/grpc/message.ex and program routines 'Elixir.GRPC.Compressor.Gzip':decompress/1, 'Elixir.GRPC.Message':from_data/2. 'Elixir.GRPC.Compressor.Gzip':decompress/1 calls :zlib.gunzip/1 directly on attacker-controlled bytes with no decompressed-size limit, ratio check, or incremental decoding. Because this module is the registered gzip GRPC.Compressor implementation, it is invoked automatically whenever an incoming gRPC frame carries the grpc-encoding: gzip header. :zlib.gunzip/1 allocates the entire decompressed result as a single binary, so a small highly compressible payload (for example a few kilobytes of zeros, which gzip compresses at roughly 1000:1) expands to multiple gigabytes inside a single call. The max_receive_message_length limit is enforced only against the already-decompressed message, so it provides no protection. An unauthenticated remote peer can send a single crafted frame to exhaust the BEAM node's heap and trigger an out-of-memory kill. This issue affects grpc: from 0.4.0 before 1.0.0.

Published

Date2026-06-15

Updated

Date2026-06-15

RISK INFORMATION (Score: )

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-48854

SUMMARY

Allocation of Resources Without Limits or Throttling vulnerability in elixir-grpc grpc allows unauthenticated attackers to exhaust the BEAM's memory and crash the server by streaming a large or slow-trickle unary request body. 'Elixir.GRPC.Server.Adapters.Cowboy.Handler':read_full_body/3 (lib/grpc/server/adapters/cowboy/handler.ex) accumulates every received chunk into a single growing binary with no size cap. Additionally, when the client omits the grpc-timeout header, the per-chunk read timeout resolves to :infinity, allowing a slow-trickle client to keep the connection alive indefinitely while memory grows. A single connection is sufficient to exhaust server memory and crash the node. This issue affects grpc from 0.3.1 before 1.0.0.

Published

Date2026-06-15

Updated

Date2026-06-15

RISK INFORMATION (Score: )

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-48853

SUMMARY

Deserialization of Untrusted Data and Allocation of Resources Without Limits or Throttling vulnerabilities in elixir-grpc grpc allow unauthenticated attackers to crash the BEAM node via atom table exhaustion and, when a decoded term flows into a call site that invokes it, achieve remote code execution on the server. 'Elixir.GRPC.Codec.Erlpack':decode/2 (lib/grpc/codec/erlpack.ex) calls :erlang.binary_to_term/1 on the raw gRPC message body without the :safe option, no size bound, and no type guard. Any unauthenticated peer that sends a request with Content-Type: application/grpc+erlpack can send a crafted payload that mints arbitrary new atoms (which are never garbage-collected, exhausting the bounded atom table and crashing the VM) or that encodes a fun term which, if applied anywhere downstream, executes attacker-controlled code inside the server process. This issue affects grpc from 0.4.0 before 1.0.0.

Published

Date2026-06-15

Updated

Date2026-06-15

RISK INFORMATION (Score: )

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-48723

SUMMARY

The browserstack-cypress-cli is BrowserStack's CLI which allows users to run Cypress tests on BrowserStack. Versions prior to 1.36.4 are vulnerable to OS command injection via the cypress_config_file configuration parameter. In readCypressConfigUtil.js, the loadJsFile() function constructs a shell command by interpolating the user-controlled cypress_config_filepath value into a template literal, then executes it via child_process.execSync(). Shell metacharacters in the config path (specifically " and ;) allow breaking out of the quoted argument and injecting arbitrary commands. This issue has been fixed in version 1.36.6.

Published

Date2026-06-15

Updated

Date2026-06-15

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-48599

SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in elixir-grpc grpc allows authenticated attackers to access or modify resources belonging to other users by smuggling a conflicting value for any path-bound field via the query string or request body. In 'Elixir.GRPC.Server.Transcode':map_request/5 (lib/grpc/server/transcode.ex), all three clauses use Map.merge/2 with path bindings as the first argument, giving them the lowest merge precedence. A request such as GET /users/me/profile?user_id=victim (or a POST with {"user_id": "victim"} when body: "*") yields a decoded protobuf struct where the path-bound field carries the attacker-supplied value rather than the router-extracted value. Any handler that uses the path-bound field for authorization, multi-tenancy scoping, or ownership checks is silently bypassed. This issue affects grpc from 0.8.0 before 1.0.0.

Published

Date2026-06-15

Updated

Date2026-06-15

RISK INFORMATION (Score: )

cvss4

Base Score: 7.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…